LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

EuropaBio participates at the BIO International Convention 2022 in San Diego

08/06/2022
NEWS RELEASE
Brussels, 7 June 2022 – On June 13-16 EuropaBio will lead European legislative discussions within the programme of the BIO International Convention 2022 in San Diego, California which is back in person for the first time in two years. The Convention features 100+ interactive sessions across 4 days, covering a variety of therapeutic areas, business development, digital health, patient advocacy, public policy, next-generation biotherapeutics, and the latest updates from industry experts on COVID-19 and the vaccine.

‘’We are very excited to be back in person at BIO Convention in San Diego this year and meet our members and partners from the U.S. This is the most important global business event in healthcare biotechnology and we are proud to represent Europe’s advancing science, business and policy together with members, through the programme and EuropaBio hosted networking events. We will enjoy every moment of the global community being back together”, said Dr Claire Skentelbery, Director General of EuropaBio.

On June 12, EuropaBio’s Director General Dr Claire Skentelbery will participate in the International Council of Biotechnology Associations (ICBA) Annual Meeting. The ICBA is a coalition of non-profit, national biotechnology trade associations which is the global voice of the industry in international for a, with the goal of promoting continued innovation in the human health, agriculture, and industrial and environmental sectors. Dr Skentelbery has been nominated for the Vice Chair position of ICBA in 2022 with the elections taking place on the day of the meeting.

On June 13 (18.20-20:00 PDT), EuropaBio together with the European Innovation Council, Estonian Business and Innovation Agency, the Italian Trade Agency and the Switzerland Global Enterprise, hosts an invite-only evening reception celebrating the biotechnology strength of Europe in the world.

On June 15 (11:00 AM-12:00 PM PDT) EuropaBio will lead a panel discussion ‘’The big bang in pharma legislation: A European epicentre shaping global healthcare and competitive industry’’ at BIO and invites all delegates to join us to discuss the future of healthcare innovation as impacted by European changes.

Panel focus:
• The drive for reform – the world is changing and with it must change the pathway for medicines so that all patients benefit;
• What do SMEs, mid-sized and multi-national companies need from legislation to ensure they can deliver innovation in the long term?
• When change is inevitable, how does industry roll up its shelves and help collectively drive a new future, rather than waiting for it to be imposed?
• How will European reform impact the global biopharma sector in a time of geopolitical realignment and regrowth?

More information, the list of speakers and registration are here.

Are you interested in meeting EuropaBio representatives at BIO International Convention in San Diego? Please get in touch with Dr Claire Skentelbery, Director General, EuropaBio; Dovile Sandaraite, Communications Manager, EuropaBio.

EuropaBio at BIO 2022


Download
2022_06_G_PR_EuropaBio-at-BIO-2022Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
26/06/2025

EuropaBio AGM 2025: Association Chair, Executive Committee and Board announced


Read more
25/06/2025

Hawkwood Biotech joins EuropaBio: Supporting Industrial Biotech with their Critical Challenges


Read more

Important links

  • Industrial Decarbonisation Accelerator Act – EuropaBio Position
  • EuropaBio Position on the Critical Medicines Act

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.